netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB researchers honored with 2018 António Champalimaud Vision Award

Prestigious award is for the scientists’ work, which led to the first gene therapy for an inherited disease.

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research, which collectively led to the development and 2017 FDA approval of Luxturnaä, a successful treatment for a type of Leber congenital amaurosis (LCA).  LCA is a genetic cause of childhood blindness.  Their work also demonstrated the potential for future developments in gene therapy for other inherited diseases, and led to the first gene therapy for an inherited human disease.  The RPB-associated awardees include: 

  • Jean Bennett, MD PhD, FARVO, of the University of Pennsylvania School of Medicine. Bennett is the recipient of multiple awards from RPB, including a Career Development Award (1992), Special Scholar Award (2000), Lew R. Wasserman Merit Award (2004) and Senior Scientific Investigator Award (2007).
  • Albert Maguire, MD, of the Children's Hospital of Philadelphia, who received RPB’s Physician-Scientist Award in 2001.
  • Samuel Jacobson, MD, PhD, of the Scheie Eye Institute, University of Pennsylvania School of Medicine, 2000 recipient of the RPB Senior Scientific Investigator Award.
  • William Hauswirth, PhD, of the University of Florida College of Medicine, who received the Senior Scientific Investigator Award in 1997.
  • Robin Ali, PhD, FMedSci, of the Institute of Ophthalmology of the University College of London. Ali has been a member of the RPB Scientific Advisory Panel since 2015.

The five – and two others who will receive the Champalimaud Award – will share a 1 million Euro prize.  The awardees will also present a special lecture at ARVO 2019 in Vancouver.

The António Champalimaud Vision Award is supported by Vision 2020 - The Right to Sight, a global blindness-prevention initiative launched in collaboration with the World Health Organization and the International Agency for the Prevention of Blindness.

 lEARN MORE ABOUT THE AWARD

 

Related News: Feature Story, For the Media, Gene Therapy, Top Story

RPB Logo

Research to Prevent Blindness Opens Applications for Vision Research Grants

The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.

Read More

 
RPB logo

Vision Research Funding Partnership Event Takes Place Today

Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.

Read More

 
Dr. Alex Huang

Research to Prevent Blindness and Alcon Award Glaucoma Grant

Dr. Alex Huang of the University of California San Diego School of Medicine will study glaucoma filtration surgeries with the aim of improving surgical success for lowering eye pressure and providing neuroprotection.

Read More

 
clock icon

Researchers Build An “Aging Clock” To Help Treat Eye Disease

The new way to measure ocular aging opens treatment avenues for numerous eye diseases.

Read More

 
RPB Logo

Research to Prevent Blindness and the American Academy of Ophthalmology Award Big Data Research Grants for Improved Patient Care

The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research.

Read More

 
RPB logo

In Memoriam: Herbert J. Siegel

RPB acknowledges the passing of a dedicated former Board member.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.